Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease

被引:13
|
作者
Norimatsu, Kenji [1 ]
Kuwano, Takashi [1 ]
Miura, Shin-ichiro [1 ,2 ]
Shimizu, Tomohiko [1 ]
Shiga, Yuhei [1 ]
Suematsu, Yasunori [1 ]
Miyase, Yuiko [1 ]
Adachi, Sen [1 ]
Nakamura, Ayumi [1 ]
Imaizumi, Satoshi [1 ]
Iwata, Atsushi [1 ]
Nishikawa, Hiroaki [1 ]
Uehara, Yoshinari [1 ,2 ]
Saku, Keijiro [1 ,2 ]
机构
[1] Fukuoka Univ, Sch Med, Dept Cardiol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Mol Cardiovasc Therapeut, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan
关键词
Cholesterol efflux capacity; Coronary artery disease; Coronary computed tomography angiography; High-density lipoprotein cholesterol; HIGH-DENSITY-LIPOPROTEIN; COMPUTED-TOMOGRAPHY; CELL CHOLESTEROL; HEART; ATHEROSCLEROSIS; THERAPY; SERUM;
D O I
10.1007/s00380-016-0837-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We hypothesized that cholesterol efflux capacity is more useful than the lipid profile as a marker of the presence and the severity of coronary artery disease (CAD). Therefore, we investigated the associations between the presence and the severity of CAD and both the percentage of cholesterol efflux capacity and total cholesterol efflux capacity and the lipid profile including the high-density lipoprotein cholesterol (HDL-C) level in patients who underwent coronary computed tomography angiography (CTA). The subjects consisted of 204 patients who were clinically suspected to have CAD and underwent CTA. We isolated HDL from plasma by ultracentrifugation and measured the percentage of cholesterol efflux capacity using H-3-cholesterol-labeled J774 macrophage cells and calculated total cholesterol efflux capacity as follows: the percentage of cholesterol efflux capacity/100x HDL-C levels. While the percentage of cholesterol efflux capacity was not associated with the presence or the severity of CAD, total cholesterol efflux capacity and HDL-C in patients with CAD were significantly lower than those in patients without CAD. In addition, total cholesterol efflux capacity and HDL-C, but not the percentage of cholesterol efflux capacity, significantly decreased as the number of coronary arteries with significant stenosis increased. Total cholesterol efflux capacity was positively correlated with HDL-C, whereas the percentage of cholesterol efflux capacity showed only weak association. In a logistic regression analysis, the presence of CAD was independently associated with total cholesterol efflux capacity, in addition to age and gender. Finally, a receiver-operating characteristic curve analysis indicated that the areas under the curves for total cholesterol efflux capacity and HDL-C were similar. In conclusion, the percentage of cholesterol efflux capacity using the fixed amount of isolated HDL was not associated with CAD. On the other hand, the calculated total cholesterol efflux capacity that was dependent of HDL-C levels had a significant correlation with the presence of CAD.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [21] Cholesterol Efflux Capacity Choke Point of Reverse Cholesterol Traffic?
    Maerz, Winfried
    Ritsch, Andreas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (21) : 2488 - 2491
  • [23] HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients
    Iván Ferraz-Amaro
    María Vanesa Hernández-Hernández
    Estefanía Armas-González
    Hiurma Sánchez-Pérez
    José David Machado
    Federico Díaz-González
    Clinical Rheumatology, 2020, 39 : 1871 - 1880
  • [24] HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients
    Ferraz-Amaro, Ivan
    Vanesa Hernandez-Hernandez, Maria
    Armas-Gonzalez, Estefania
    Sanchez-Perez, Hiurma
    David Machado, Jose
    Diaz-Gonzalez, Federico
    CLINICAL RHEUMATOLOGY, 2020, 39 (06) : 1871 - 1880
  • [25] HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease
    Bauer, Lucie
    Kern, Sabine
    Rogacev, Kyrill S.
    Emrich, Insa E.
    Zawada, Adam
    Fliser, Danilo
    Heinemann, Akos
    Heine, Gunnar H.
    Marsche, Gunther
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (02) : 246 - 247
  • [26] Tweaking the cholesterol efflux capacity of reconstituted HDL
    Ma, Cheng-I J.
    Beckstead, Jennifer A.
    Thompson, Airlia
    Hafiane, Anouar
    Wang, Rui Hao Leo
    Ryan, Robert O.
    Kiss, Robert S.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2012, 90 (05): : 636 - 645
  • [27] HDL Cholesterol Efflux Capacity and Cardiovascular Events
    Ritsch, Andreas
    Scharnagl, Hubert
    Maerz, Winfried
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19): : 1870 - 1871
  • [28] HDL CHOLESTEROL EFFLUX CAPACITY AND CARDIOVASCULAR MORTALITY
    Ritsch, A.
    Duerr, A.
    Kahler, P.
    Stojakovic, T.
    Silbernagel, G.
    Scharnagl, H.
    Kleber, M. E.
    Maerz, W.
    ATHEROSCLEROSIS, 2015, 241 (01) : E28 - E28
  • [29] Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
    Elena M. Yubero-Serrano
    Juan F. Alcalá-Diaz
    Francisco M. Gutierrez-Mariscal
    Antonio P. Arenas-de Larriva
    Patricia J. Peña-Orihuela
    Ruth Blanco-Rojo
    Javier Martinez-Botas
    Jose D. Torres-Peña
    Pablo Perez-Martinez
    Jose M. Ordovas
    Javier Delgado-Lista
    Diego Gómez-Coronado
    Jose Lopez-Miranda
    Cardiovascular Diabetology, 20
  • [30] Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease
    Funabashi, S.
    Kataoka, Y.
    Ogura, M.
    Kuyama, N.
    Otsuka, F.
    Asaumi, Y.
    Noguchi, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2635 - 2635